CIDRAP newsletters options
Cell culture–based inactivated influenza vaccine (ccIIV) was not significantly more effective than egg-based IIV (ebIIV) against influenza A during the 2017-18 flu season, according to new data presented at IDWeek that have not been peer reviewed.
Minnesota recently reported 6 cases, and some of Colorado's cases were associated with EV-D71.
The flurry of new cases include 3 classified as probable involving people buried before samples were obtained.
The US Food and Drug Administration (FDA) on Oct 5 announced that it approved expanded use of Gardasil 9 human papillomavirus (HPV) vaccine for women and men 27 through 45 years old. The vaccine prevents certain cancers and diseases caused by the nine HPV types contained in the vaccine.
A new report from the Wellcome Trust and Boston Consulting Group identifies antibiotic-resistant pathogens that could be addressed by increased vaccine uptake and vaccine development.
The CDC said only one third of the cases were linked to two major outbreaks and that it is exploring if a change in testing practices contributed to more detections.
The new study sheds light on prescribing missed in other studies, including for conditions without an in-patient visit.
A pilot study conducted by researchers at Johns Hopkins has found that using a special antiseptic shampoo and wipes to decolonize therapy dogs before and between visits with young cancer patients can reduce the transmission of methicillin-resistant Staphylococcus aureus (MRSA). The findings were presented today at IDWeek 2018.
During a 4-day pause of fighting in an ongoing conflict, 306,000 Yemenis, including 164,000 children under the age of 15, were vaccinated with the cholera vaccine, according to an update today from the World Health Organization (WHO).
In new developments, an attack in Butembo injured burial team members, and a rights group called for the International Criminal Court to expand its probe into Beni attacks as outbreak cases reach 165.
Fifty-seven people have fallen ill with salmonellosis, while Listeria has caused 1 death.
The Saudi Arabian Ministry of Health (MOH) today recorded a new case of MERS-CoV for epidemiologic week 40, which is this week.
A 49-year-old man from Najran was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). The MOH said the man was hospitalized and likely exposed to the virus in a community setting. He had not reported recent contact with camels, a known risk factor.
The results of a small clinical trial in France show that a topical treatment containing a cocktail of bacteriophages successfully reduced bacterial burden in patients with infected burn wounds, but at a significantly slower rate than standard of care. The findings appeared yesterday in The Lancet Infectious Diseases.
Of 32 Saudi MERS cases over the summer, 12 were part of illness clusters.
Temperature probes increased the risk of infection nearly 7 times.
Massachusetts General Hospital (MGH) said today it was part of an international multisite study evaluating ZMapp, an experimental Ebola treatment. ZMapp contains three antibodies and is being used in the current outbreak in the Democratic Republic of the Congo (DRC)
Both newly reported patients belonged to families that refused Ebola vaccination, and one of them died.
The results of a phase 3 randomized, controlled clinical trial show that monotherapy with the antibiotic/beta-lacatamase inhibitor combination Vabomere (meropenem-vaborbactam) in patients with carbapenem-resistant Enterobacteriaceae (CRE) infections was associated with increased clinical cure, decreased mortality, and reduced kidney toxicity compared with the best available therapy (BAT).
As the Southern Hemisphere's flu season winds down, disease levels in temperate South American and southern Africa countries decreased or have peaked in recent weeks, according to the latest global flu update from the World Health Organization (WHO).
